Health
Pfizer, BioNTech Seek US Emergency OK for COVID-19 Vaccine in Adolescents – Voice of America
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15. The vaccine is currently…
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15.
The vaccine is currently authorized for emergency use in the United States for people age 16 and older. The companies said Friday that they requested an expansion of the authorization from the U.S. Food and Drug Administration (FDA) to include the younger age group.
In March, the drugmakers said the vaccine was found to be safe and effective and had produced…
-
General23 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News18 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News20 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News23 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call